Facts
as of Nov 16, 2026
Janux is developing novel immunotherapies that selectively modulate T cells to fight cancer and autoimmune diseases without causing systemic safety issues.
It is hiring: 8 open roles, 1 of them posted in the last 30 days. Its stated pay is 19% above the market estimate for the same roles.
- Headquarters
- San Diego, United States
- Founded
- 2017
- Employees
- 51-200estimated range
- Open roles
- 8Alion job postings
- Website
- januxrx.com
As of Nov 16, 2026, Alion lists 8 open roles at Janux Therapeutics | Novel T Cell Immunotherapies. Janux Therapeutics | Novel T Cell Immunotherapies is headquartered in San Diego, United States. It was founded in 2017. The median pay stated in its open roles is $302k, across 7 postings that state pay.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Postings are real
Alion truth index: B
78/100
Ghost roles
re-checked against its careers site
0%
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Hiring slowly: few roles were posted lately.
Biotech is the largest family, 33 of open roles.
1Posted in 30 days13% of open roles are fresh
13%Remote roles1 of 8
1Hiring offices
Can they hire you from United States?by your location
Likely
16 open roles are in your country: you apply locally, no move needed.
United States16On site
Remote, from elsewhere1Rare
No posting offers visa sponsorship. Remote roles: 1.
Time to fillmedian days to close a role
Janux Therapeutics | Novel T Cell Immunotherapies69 days
Market, same roles30 days
Alion signals0-100
Demand24
Pay49
Your chance57
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time−100%
Sep 7This week
Open roles a week: 4 then, 0 now
Are the postings real?
B
78 / 100Janux Therapeutics | Novel T Cell Immunotherapies scores B on the Alion truth index (A is best, E worst), measured over 3 open roles re-checked against its own hiring board: 0% look like ghost listings, 67% have gone stale and 0% are the same role posted again. Its roles close in a median of 69 days.
Ghost roles0%
Gone stale67%
Reposted0%
Where the openings areshare of open roles · trend
Biotech33▼
Science & Research22▼
Administrative11▲
Finance11▲
Operations11▲
Industrial Engineering11▲
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
Pays 19% above the market estimate for the same roles.
$302kMedianmarket estimate $249k
$161k – $316kTypical rangeUSD a year
$450kHighest paying roleVice President / Senior Vice President, Clinical Development (AID)
Pay by levelmiddle half of stated pay, median marked · dashed: market median $249k
Head+7$316k$296k – $347k
$0$100k$200k$300k$400k
Source: the pay stated in the company's postings, normalised to USD a year
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
San DiegoBusiest site
Source: office addresses in postings and company registers
Technologies named in job postings at Janux Therapeutics | Novel T Cell Immunotherapies over the last 12 months, by layer, with the share of postings for each.
12Technologies in use
12Postings analysed
51/100Stack modernity
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site
Newsroom
top 5%Web presenceof 133.2M domains by links, Common Crawl
Sources: the outlets named on each headline, each story once